Seeing Is Believing
Aerovate Therapeutics's activity chart (see below) currently has 7 price targets and 7 ratings on display.
Analysts average stock forecasts to be materialized ratio is 29.63% with an average time for these price targets to be met of 39.56 days.
Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 18-Jun-2024. First documented stock forecast 26-Jul-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$36
2 years 20 days ago
(18-Jun-2024)
0/1 (0%)
$13.53 (60.21%)
Hold Since 18-Jun-2024
$35
$-56.4 (-61.71%)
2 years 21 days ago
(18-Jun-2024)
0/1 (0%)
$-13.09 (-27.22%)
Hold Since 18-Jun-2024
$27
$-64.4 (-70.46%)
2 years 21 days ago
(18-Jun-2024)
0/1 (0%)
$-21.09 (-43.86%)
Hold
$27
2 years 21 days ago
(17-Jun-2024)
2/2 (100%)
$8.97 (49.75%)
90
$41
2 years 21 days ago
(17-Jun-2024)
0/3 (0%)
$21.09 (105.93%)
What is AVTE (Aerovate Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AVTE (Aerovate Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AVTE (Aerovate Therapeutics)?
Which analyst is the currently most bullish on AVTE (Aerovate Therapeutics)?
Which analyst is the currently most reserved on AVTE (Aerovate Therapeutics)?